Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2008

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Bacille of Calmette-Guerin

A single intracutaneous dose of 0.1 mL freeze-dried BCG (1 mg/mL; Berna Institute, Basel).

OTHER

placebo

subcutaneous administration of physiologic solution

Trial Locations (1)

00100

Department of Neurology - University of Rome La Sapienza, Rome

All Listed Sponsors
collaborator

Italian Multiple Sclerosis Foundation

OTHER

collaborator

Istituto Superiore di Sanità

OTHER

lead

S. Andrea Hospital

OTHER

NCT00202410 - Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis | Biotech Hunter | Biotech Hunter